EUVIMEDEUVIMED entdecken
Crossref

eBIMIC: development of a web platform for real-time access to cumulative antimicrobial susceptibility reports and its potential impact on evidence-based antibiotic prescribing in bacteremia

Silvia Hernández, Javier Colomina, Estela Giménez, Andrea Medina, Katherine Villarruel, Eliseo Albert, David Navarro, Ignacio Torres

European Journal of Clinical Microbiology & Infectious Diseases · 2026

DOI: 10.1007/s10096-026-05413-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2026. Verfasst von Silvia Hernández und 7 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Spain. Av. Blasco Ibáñez 17, 46010, Valencia, Spain. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteremia, Internet, Bacteria. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Timely knowledge of local epidemiology is essential for guiding appropriate antibiotic therapy in severe infections such as bloodstream infections (BSI). In 2024, we developed "eBIMIC", a web-based application that enables real-time parameterized consultation of cumulative antimicrobial susceptibility data base on demographic and microbiological parameters. Avaliable to all clinicians within the Clínico-Malvarrosa Health Department (Valencia, Spain). This study evaluated its potential impact on optimizing antibiotic therapy in BSI patients admitted from the Emergency Department (ED). METHODS: We retrospectively analyzed 212 adult patients with positive blood cultures from the ED between January and December 2023. Empirical and semi-targeted treatments were compared with eBIMIC-based susceptibility data using patient sex, age, ED location, and Gram stain results (for empirical therapy), or species identification (for semi-targeted therapy). A susceptibility rate ≥ 85% was considered optimal. Potential for antibiotic de-escalation was also evaluated. RESULTS: Empirical therapy was adequate in 85% of cases, and eBIMIC correctly predicted optimal coverage in 74.4% of them. Among inadequate treatments, eBIMIC successfully identified 78.1% as suboptimal. Concordance with semi-targeted therapy was high (92.6%). eBIMIC also revealed opportunities for safe de-escalation in 86% of patients receiving high-impact antibiotics. Retrospective simulation confirmed that eBIMIC would have recommended at least one effective empirical option in 99.5% of cases and matched in vitro susceptibility patterns in 92.9% of semi-targeted therapies. CONCLUSION: eBIMIC is a mobile-accessible platform that integrates real-time microbiological data with demographic parameters to support individualized antibiotic selection and de-escalation. Its implementation has the potential to enhance antimicrobial stewardship by promoting timely, evidence-based therapeutic decisions in routine clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteremiaInternetBacteriaHumansRetrospective StudiesFemaleMaleMicrobial Sensitivity TestsAgedMiddle AgedSpainAdultAged, 80 and overEmergency Service, HospitalAntimicrobial Stewardship

Stichwörter der Autor:innen

Antibiotic de-escalationAntimicrobial stewardshipBacteremiaEBIMICEmpirical therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Spain. Av. Blasco Ibáñez 17, 46010, Valencia, Spain.
  • Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
  • Microbiology Service, Hospital Clínico Universitario, Instituto de Investigación INCLIVA, Spain. Av. Blasco Ibáñez 17, 46010, Valencia, Spain. nachotfink@gmail.com.

Zitieren

APA

Hernández, S., Colomina, J., Giménez, E., Medina, A., Villarruel, K., Albert, E., Navarro, D., & Torres, I. (2026). eBIMIC: development of a web platform for real-time access to cumulative antimicrobial susceptibility reports and its potential impact on evidence-based antibiotic prescribing in bacteremia. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-026-05413-8

Vancouver

Hernández S, Colomina J, Giménez E, Medina A, Villarruel K, Albert E, et al. eBIMIC: development of a web platform for real-time access to cumulative antimicrobial susceptibility reports and its potential impact on evidence-based antibiotic prescribing in bacteremia. European Journal of Clinical Microbiology & Infectious Diseases. 2026. doi:10.1007/s10096-026-05413-8

BibTeX
@article{Hernndez2026,
  author = {Hernández, Silvia and Colomina, Javier and Giménez, Estela and Medina, Andrea and Villarruel, Katherine and Albert, Eliseo and Navarro, David and Torres, Ignacio},
  title = {eBIMIC: development of a web platform for real-time access to cumulative antimicrobial susceptibility reports and its potential impact on evidence-based antibiotic prescribing in bacteremia},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2026},
  doi = {10.1007/s10096-026-05413-8}
}
Kostenlos starten →